We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Diabetic Charcot Foot Surgery Shows High Success Rate

By HospiMedica International staff writers
Posted on 26 Dec 2017
Nearly 80% of diabetic patients with severe Charcot foot inflammation are able to walk normally again following surgery, according to a new study.

Researchers at Loyola University Health System (Chicago, IL, USA) conducted a retrospective study of 214 patients who underwent surgical reconstruction of deformities associated with mid-tarsal Charcot foot arthropathy over a 12-year period. More...
Surgery included resection of infection when present, Achilles tendon lengthening, correction of the structural deformity by wedge resection, and immobilization with a three-level static circular external fixator. Clinical outcomes were based on limb salvage, resolution of infection, and the functional metric of the ability to walk with commercially available therapeutic footwear.

The results revealed that 173 of the 223 feet operated on had good or excellent outcomes, defined as being free of ulcers and infections and able to walk outside using off-the-shelf therapeutic footwear and custom foot braces. Success rates varied according to the type of foot deformity; patients with a valgus deformity pattern had an 87% success rate; patients with a dislocation pattern deformity had a 70.3% success rate; and those with a varus deformity pattern had a 56.3% success rate. Seven patients died of unrelated causes within a year of surgery, and 15 underwent partial- or whole-foot amputations. The study was published on November 27, 2017, in Foot and Ankle International.

“Operative correction of the acquired deformity of Charcot foot arthropathy was performed with a goal of improving quality of life. The clinical outcomes achieved in this retrospective case series appear to support the modern paradigm of operative correction of deformity in this complex patient population,” concluded lead author orthopedic surgeon Michael Pinzur, MD. “This realistic appreciation of outcome expectations should both be helpful in counseling patients on the risk-benefit ratio associated with surgery, and provide a benchmark to measure newer strategies of treatment.”

First described in 1883, diabetic Charcot foot is characterized by varying degrees of bone and joint disorganization secondary to underlying neuropathy, trauma, and perturbations of bone metabolism. The bones are weakened enough to fracture, and with continued walking, the foot eventually deforms. The hallmark deformity is midfoot collapse, described as a “rocker-bottom” foot, although it can appear in other joints and with other presentations.

Related Links:
Loyola University Health System


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.